FDA 483 - The Procter & Gamble Manufacturing Company - November 17, 2017

The FDA inspected The Procter & Gamble Manufacturing Company in Greensboro, NC, an OTC drug manufacturer. The inspection revealed significant deficiencies across multiple areas, including a lack of process validation for packaging and labeling, inadequate supplier qualification, and poor complaint handling procedures. Additionally, the firm failed to properly maintain and sanitize equipment and utensils, leading to potential contamination risks.